Pfizer Forecasts $54 Billion in Sales This Year as Demand for COVID-19 Vaccine and Treatment Pill Continues

Contact Your Elected Officials
The Epoch Times Header

Pfizer on Tuesday said it expects to see continued demand for its products this year, forecasting $54 billion in combined sales of its COVID-19 vaccine shots and antiviral pills.

The American pharmaceutical and biotechnology giant said it expects to sell $32 billion of its vaccinations and $22 billion of its antiviral COVID-19 treatment pill Paxlovid in 2022 as demand for the products continues.

Those numbers are based on contracts signed or close to being signed as of late January, Pfizer said.

Paxlovid was authorized for emergency use by the U.S. Food and Drug Administration (FDA) in December and is aimed at helping patients who are suffering from “mild-to-moderate” COVID-19 symptoms from becoming so sick that they need to be hospitalized, Pfizer has said.

In its Fourth-Quarter and Full-Year 2021 Results forecast, Pfizer said increased sales of its COVID-19 treatments will see its revenue boosted to around $100 billion this year.

Overall, Pfizer forecast 2022 sales of $98 billion to $102 billion.

Last year, Pfizer made nearly $37 billion in sales from its COVID-19 vaccine, also known as Comirnaty, making it one of the most lucrative pharmaceutical products in history. Paxlovid sales last year totaled $76 million.

In total for the full year of 2021, Pfizer’s revenue almost doubled to $81.3 billion from $41.6 billion in 2020.

However, the company’s bumper sales faced criticism from campaigners who accused it of “pandemic profiteering” and “ripping off public health systems.”

Tim Bierley, a pharma campaigner at the group Global Justice Now, said: “The development of mRNA vaccines should have revolutionized the global COVID response. But we’ve let Pfizer withhold this essential medical innovation from much of the world, all while ripping off public health systems with an eye-watering mark-up.”

“Right now, there are billions of people who cannot access COVID-19 vaccines and treatments. Many are in countries with the facilities needed to manufacture mRNA jabs, but Pfizer’s jealous guarding of its patent stands in the way. And we’re seeing thousands of preventable deaths each day as a result.”

Bierley said Pfizer’s record-high sales were “nothing short of pandemic profiteering” and that the company was now “richer than most countries” while calling for the company to suspend its intellectual property and “break vaccine monopolies.”

“It has made more than enough money from this crisis,” Bierley added.

Despite forecasting increased sales next year, Pfizer shares fell more than 4 percent on Tuesday as investors expected the company’s guidance on its 2022 earnings per share to be higher than $6.35 to $6.55, according to Evercore ISI analyst Umer Raffat.

Pfizer also fell short of Wall Street estimates, which had forecast sales of $33.79 billion for the COVID-19 vaccine and $22.88 billion for Paxlovid, according to Refinitiv data.

By Katabella Roberts

Read Full Article on TheEpochTimes.com

The Epoch Times
The Epoch Timeshttps://www.theepochtimes.com/
Tired of biased news? The Epoch Times is truthful, factual news that other media outlets don't report. No spin. No agenda. Just honest journalism like it used to be.

Obama Floats ‘New Forms of [State-Controlled] Journalism’

Notorious nemesis of civil liberties one and all, Barack Obama, ]apparently endorses a heavy state hand in the “regulation” of information.

Privilege Is Financial, Not Racial

If we stay divided by race, we’ll keep fighting each other while the true elites of all races thrive unseen, counting their wealth in comfort.

California Repeats Illinois’ History, PROSECUTE Newsom!

California may have improperly licensed 62,000 illegal aliens as Commercial Driver’s License (CDL) truck drivers.

The Stage Is Set For A US-Instigated Security Dilemma Between The Eurasian Rimland & Heartland

The US sends mixed signals on the Sino-Russo alliance after Trump downplayed concerns while Hegseth said he was ordered to “re-establish deterrence.”

Chambers of Horror

Using a shutdown to legislate is like using a flame thrower to light a candle, it provides light momentarily but destroys everything in its path.

Vance Warns Holiday Travel Could Be ‘Disaster’ If Government Does Not Reopen

Vice President JD Vance warned on Thursday that holiday travel will be a “disaster” if the government shutdown does not end.

Trump Admin Cuts Quota for Refugees, Prioritizes Afrikaners

Trump admin slashed quota for refugees and prioritized Afrikaners “and other victims of illegal or unjust discrimination in their respective homelands.”

DHS: 8,000 Percent Jump in Death Threats Against ICE Officers

DHS reports an 8,000% surge in death threats against U.S. immigration officers, raising alarm over safety concerns for federal personnel.

Federal Judge Weighs Forcing USDA to Pay SNAP Benefits Despite Shutdown

A judge weighed forcing the USDA to use a $5 billion fund to prevent a lapse in the national food stamp program amid looming funding shortfalls.

US, South Korea Finalize Trade Deal Reducing Tariffs, Boosting American Investment

The U.S. and South Korea finalized a major trade deal on Oct. 29 as President Trump wrapped up the final hours of his Asian tour on the Korean Peninsula.

Trump, Japanese PM Sign Critical Minerals, Rare Earths Deal

The U.S. president visited Tokyo on the second leg...

Trump Hikes Canada’s Tariffs by 10 Percent for Not Pulling Anti-Tariff Ad Immediately

Trump announced he will increase tariffs on Canada by 10% after ad by provincial government of Ontario misrepresented President Reagan’s speech on tariffs.

Trump Rolls Back Emissions Rules on Copper Smelters

President Trump issued a proclamation aimed at reversing a Biden-era environmental rule that enforced stricter air emission standards on copper smelters.
spot_img

Related Articles

Popular Categories

MAGA Business Central